Bavarian Nordic named Tarja Stenvall as its next President and CEO, effective Oct. 15, succeeding Paul Chaplin. Stenvall previously led Sanofi’s diabetes and cardiovascular franchise as an SVP and held roles across Europe and Latin America, while Chaplin has served as CEO since 2014 following a multi-decade tenure at the company.